MODERNA, INC.

MRNA
Real-time Estimate Quote. Real-time Estimate  - 12/01 08:10:28 am
342.8USD -2.73%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and three in phase I.

Number of employees : 1 300 people.
Sales per Business
20192020
Transformative Medicines60.21100%803.40100%
USD in Million
Sales per region
2020
United States764.5395.2%
Rest of World38.874.8%
USD in Million
Managers
Name Title
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Paul Burton Chief Medical Officer
Paul L. Sagan Independent Non-Executive Director
Robert S. Langer Independent Non-Executive Director
Stephen A. Berenson Independent Non-Executive Director
Francois Nader Independent Non-Executive Director
Shareholders
Name Equities %
Baillie Gifford & Co. 42,217,354 10.5%
The Vanguard Group, Inc. 25,705,125 6.37%
Stéphane Bancel 22,168,120 5.49%
Flagship Pioneering 17,581,016 4.36%
SSgA Funds Management, Inc. 13,957,581 3.46%
Robert Langer 11,509,357 2.85%
BlackRock Fund Advisors 7,588,443 1.88%
Coatue Management LLC 6,048,926 1.50%
Geode Capital Management LLC 5,759,961 1.43%
Fidelity Management & Research Co. LLC 5,142,172 1.27%
Company contact information
200 Square Technology
MA 02139 Cambridge, Massachusetts


Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://www.modernatx.com
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Reuters Code :  MRNA.O
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827
ICON PUBLIC LIMITED COMPANY38.72%22 016
ALNYLAM PHARMACEUTICALS, INC.41.42%21 983
PHARMARON BEIJING CO., LTD.50.84%21 600
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.71.54%19 726
BIO-TECHNE CORPORATION48.65%18 549
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.46.43%18 463
HANGZHOU TIGERMED CONSULTING CO., LTD-15.05%17 873
PPD, INC.37.64%16 551
NOVAVAX, INC.87.10%15 774
INCYTE CORPORATION-22.14%14 959
QIAGEN N.V.5.24%12 516
GENSCRIPT BIOTECH CORPORATION263.48%11 045
PRA HEALTH SCIENCES, INC.0.00%10 965
BACHEM HOLDING AG67.89%10 619
SYNEOS HEALTH, INC.42.61%10 075
INTELLIA THERAPEUTICS, INC.111.42%8 559
Brand Portfolio
MODERNA
MODERNA
MODERNA THERAPEUTICS
MODERNA THERAPEUTICS
» More brands of Moderna, Inc.